ProCE Banner Activity

My Experiences Administering Checkpoint Inhibitor Therapy in Patients With Preexisting Autoimmune Disease

Clinical Thought
How do preexisting autoimmune conditions such as ulcerative colitis and rheumatoid arthritis affect management of melanoma with checkpoint inhibitors?

Released: February 08, 2017

Expiration: February 07, 2018

No longer available for credit.

Share

Faculty

Osama E. Rahma

Osama E. Rahma, MD

Member of the Faculty of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Boston, Massachusetts

Provided by

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by an educational grant from

Merck Oncology

Faculty Disclosure

Primary Author

Osama E. Rahma, MD

Member of the Faculty of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Boston, Massachusetts

Osama E. Rahma, MD, has disclosed that he has received fees for non-CME/CE services from Merck.